CINECA IRIS Institutional Research Information System

FUNEL, NICCOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.092
EU - Europa 4.653
AS - Asia 4.304
SA - Sud America 547
AF - Africa 246
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 22.859
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.258
CA - Canada 4.768
SG - Singapore 1.325
IT - Italia 1.320
CN - Cina 1.224
PL - Polonia 1.044
HK - Hong Kong 663
SE - Svezia 554
BR - Brasile 440
VN - Vietnam 359
DE - Germania 342
BG - Bulgaria 294
GB - Regno Unito 225
FR - Francia 203
IN - India 170
TR - Turchia 141
FI - Finlandia 135
RU - Federazione Russa 132
JP - Giappone 128
AT - Austria 89
UA - Ucraina 89
CI - Costa d'Avorio 76
NL - Olanda 53
CH - Svizzera 46
SN - Senegal 43
KR - Corea 42
BD - Bangladesh 39
NG - Nigeria 33
AR - Argentina 30
BE - Belgio 29
MX - Messico 28
IQ - Iraq 26
PK - Pakistan 25
EC - Ecuador 23
IE - Irlanda 22
ES - Italia 21
MA - Marocco 21
ZA - Sudafrica 21
TW - Taiwan 18
ID - Indonesia 17
SA - Arabia Saudita 17
VE - Venezuela 17
EG - Egitto 15
TN - Tunisia 14
UZ - Uzbekistan 14
CO - Colombia 12
JO - Giordania 12
CZ - Repubblica Ceca 11
AE - Emirati Arabi Uniti 10
PH - Filippine 10
AU - Australia 9
CL - Cile 8
CR - Costa Rica 8
IL - Israele 8
MY - Malesia 8
NP - Nepal 7
BJ - Benin 6
LT - Lituania 6
PA - Panama 6
PT - Portogallo 6
PY - Paraguay 6
TH - Thailandia 6
AZ - Azerbaigian 5
DZ - Algeria 5
EU - Europa 5
JM - Giamaica 5
KZ - Kazakistan 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
ET - Etiopia 4
IR - Iran 4
KE - Kenya 4
LU - Lussemburgo 4
OM - Oman 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AL - Albania 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HU - Ungheria 3
MO - Macao, regione amministrativa speciale della Cina 3
NO - Norvegia 3
PS - Palestinian Territory 3
RO - Romania 3
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
GE - Georgia 2
HN - Honduras 2
KG - Kirghizistan 2
KY - Cayman, isole 2
LB - Libano 2
NZ - Nuova Zelanda 2
PE - Perù 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BM - Bermuda 1
Totale 22.848
Salva come PNG Salva come JPEG
Città #
Montreal 4.591
Ashburn 864
Woodbridge 837
Singapore 711
Hong Kong 657
Fairfield 538
Santa Clara 521
Chandler 513
Ann Arbor 487
Dallas 433
San Jose 399
Houston 394
Milan 330
Sofia 293
Shanghai 269
Beijing 226
Wilmington 210
Seattle 201
New York 196
Cambridge 194
Serra 180
Boardman 151
Princeton 144
Ottawa 139
Jacksonville 120
Los Angeles 111
Lawrence 110
Tokyo 105
Lauterbourg 104
Dearborn 100
Ho Chi Minh City 95
Pisa 93
Florence 87
Medford 85
London 80
Vienna 79
Abidjan 76
Izmir 76
Nanjing 73
Boulder 67
Frankfurt am Main 59
Hanoi 59
Rome 59
Des Moines 55
Helsinki 55
Munich 51
Redwood City 47
Council Bluffs 43
Dakar 42
Buffalo 41
Bern 40
Istanbul 39
San Diego 38
Redondo Beach 37
Hefei 36
Dong Ket 33
Lagos 33
Nanchang 33
Hyderabad 32
São Paulo 32
Chicago 29
Kunming 29
Washington 29
Seoul 28
Nuremberg 27
Shenyang 27
Bremen 25
Düsseldorf 25
Ogden 25
Brussels 24
Orem 24
Columbus 22
Fuzhou 22
Livorno 22
Guangzhou 21
Grafing 20
Jüchen 20
Kent 19
The Dalles 19
Warsaw 19
Lucca 17
Paris 15
Changsha 14
Manchester 14
Norwalk 14
Chennai 13
Hangzhou 13
Hebei 13
Tashkent 13
Jakarta 12
Jiaxing 12
Mumbai 12
Rio de Janeiro 12
Toronto 12
Turku 12
Amsterdam 11
Baghdad 11
Brooklyn 11
Falls Church 11
Marseille 11
Totale 16.532
Salva come PNG Salva come JPEG
Nome #
CORRELATION OF GENE EXPRESSION PROFILES WITH CLINICAL RESPONSE TO GEMCITABINE IN PANCREATIC CANCER 3.301
PANCREATIC METASTASES FROM RENAL CARCINOMA 2.565
Zebrafish embryos as avatar of patients with pancreatic cancer: preliminary results of validation a new model toward personalized medicine 308
GLUT1 and LOX inhibitors as perspective anticancer agents tackling glucose avidity and ECM remodeling in tumors 269
Sonde diagnostiche per evidenziare all’infrarosso cellule e tessuti affetti da condizioni patologiche o metaboliche 229
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine 225
Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice. 221
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models 217
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 213
Magnetic carbon nanotubes: a new tool for shepherding mesenchymal stem cells by magnetic fields 210
Abdominal ultrasound scan for the follow-up of pancreatic cystic lesions: could it play a role as a safe and cost-saving alternative to the routine MRI? 210
Diagnostic probes to detect cells and tissues afflicted with a pathological or metabolic condition by means of infrared spectroscopy 208
Discovery of N-Hydroxyindole-Based Inhibitors of Human Lactate Dehydrogenase Isoform a (LDH-A) as Starvation Agents against Cancer Cells 199
Robotic-assisted versus open left pancreatectomy for cystic tumours: A single-centre experience 196
Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours 194
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 193
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer 190
Mesenchymal stem cells and magnetic nanoparticles: in vitro studies and in vivo protocol validation for cellular homing into a target organ by magnetic fields 186
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 186
Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia 179
EUS-FNA wet technique for the pre-operative diagnosis of 31 solid pancreatic tumors: Pisa experience 177
Epigenetic expression of MUC5AC in metastatic pancreatic patients using RNA-scope technology and immunohistochemistry 176
RNA-SCOPE TECHNOLOGY AND IMMUNOHISTOCHEMISTRY REVEAL LOW EXPRESSION OF MUC5AC IN METASTATIC PANCREATIC PATIENTS: EPIGENETIC PITFALLS OR A BETTER DISEASE STATUS? 175
Cellular Transfection Evidence in Pancreatic Tumor Primary Cell Cultures Through Electroporation of Green Fluorescent Protein (GFP) 174
FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer 173
Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine 171
Liver fat accumulation and isolated islets function in non-diabetic and type 2 diabetic subjects 168
Role of CYB5A in pancreatic cancer prognosis and autophagy modulation. 168
Homozygosis Mutation in K-ras Oncogene in Primary Cell Culture from Pancreatic Ductal Adenocarcinoma. Characteristic of the Tumor or Adaptation in Vitro? 167
Preclinical emergence of novel lactate dehydrogenase inhibitors as potent antitumor agents in hypoxic models of pancreatic cancer: molecular mechanisms underlying their synergistic interaction with gemcitabine 167
THE IMMUNOHISTOCHEMICAL SCORE OF CDX2, CK7 AND CK 20 CAN IDENTIFY PATHOLOGICAL SUBTYPES OF AMPULLARY ADENOCARCINOMAS AND THEIR PROGNOSIS 167
SINGLE INSTITUTION EXPERIENCE WITH PANCREATECTOMIES ASSOCIATED TO VASCULAR RESECTION 166
Ampullary adenocarcinomas: The immunohistochemical score of CDX2, CK7 and CK 20 identify pathological subtypes and their prognosis 166
The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies 166
Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia. 165
The MEK1/2 inhibitor pimasertib enhances gemcitabine efficacy-letter 163
Lights and shadows of molecular pathology and immunotherapy in adjuvant setting of patients with pancreatic ductal adenocarcinoma: Tumor volume and microsatellite instability inversely affect early progression free survival 163
Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma 162
A PERSONAL INVAGINATION PANCREATICOJEJUNOSTOMY TECHNIQUE AFTER PANCREATICODUODENECTOMY: DESCRIPTION, TECHNICAL DETAILS AND RESULTS 162
The biology of regulatory pathways of miRNAs, mRNAs and proteins unravels a specific -omics network in tumor-educated platelets from pancreatic cancer patients 162
DUODENO-PANCREATECTOMY WITHOUT VASCULAR RESECTION FOR ISHIKAWA TYPE B ADENOCARCINOMA: UNDERTREATMENT OR NOT? 161
Genes involved in gemcitabine activity: pancreas cancer vs primary cell cultures 160
Multidetector CT in the evaluation of retroperitoneal fat tissue infiltration in ductal adenocarcinoma of the pancreatic head: correlation with histopathological findings. 160
PROGNOSTIC IMPACT OF CONSERVATIVE SURGERY FOR PANCREATIC IPMNS 160
Detailing the ultrastructure’s increase of prion protein in pancreatic adenocarcinoma 159
CHARACTERIZATION OF HUMAN ISLETS IN POLYELECTROLYTE MULTILAYER CAPSULES 158
Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger 157
Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer 157
Abstract 3082: Targeting hypoxic pancreatic cancer cells with glucose conjugated lactate dehydrogenase inhibitor NHI-Glc-2 157
CONSERVATIVE SURGERY FOR PANCREATIC IPMNS: PROGNOSTIC IMPACT ON TUMOR PROGRESSION AND ON QUALITY OF LIFE 157
MET as a potential target for the treatment of upper gastrointestinal cancers: characterization of novel c-Met inhibitors from bench to bedside. 156
EUS-FNA WET-TECHNIQUE IN 31 SOLID PANCREATIC LESIONS: PISA EXPERIENCE 156
3D IN VITRO MODEL OF PANCREATIC DUCTAL ADENOCARCINOMA: NEW STRATEGY TO STUDY PANCREATIC DUCTAL ADENOCARCINOMA 156
THE IMMUNOHISTOCHEMICAL SCORE OF CDX2, CK7 AND CK 20 IDENTIFY PATHOLOGICAL SUBTYPES AND THEIR PROGNOSIS IN AMPULLARY ADENOCARCINOMAS PATIENTS 155
Pancreatoduodenectomy without Vascular Resection in Patients with Primary Resectable Adenocarcinoma and Unilateral Venous Contact: A Matched Case Study 155
Triticum vulgare Extract Modulates Protein-Kinase B and Matrix Metalloproteinases 9 Protein Expression in BV-2 Cells: Bioactivity on Inflammatory Pathway Associated with Molecular Mechanism Wound Healing 155
Synergistic Interaction of Novel Lactate Dehydrogenase Inhibitors with Gemcitabine in Hypoxic Models of Pancreatic Cancer 154
THE ROUTINE USE OF SOMATOSTATIN ANALOGUES AFTER PANCREATODUODENECTOMY: ITS CLINICAL IMPACT BASED ON A CASE-MATCHED COMPARISON ACCORDING TO FISTULA RISK SCORE, ASA AND SURGICAL TECHNIQUE 154
Crizotinib inhibits metabolic inactivation of gemcitabine in c-Met-driven pancreatic carcinoma. 152
Tuning scaffold pore features to accomplish biomimicry in liver and pancreas 3D tumor models: a study on cancer cell aggregation, migration and morphotype transition 151
Dysregulated insulin secretion is associated with pancreatic β-cell hyperplasia and direct acinar-β-cell trans-differentiation in partially eNOS-deficient mice 149
Surgical Treatment of Neuroendocrine Tumors of the Pancreas: Results and Prognostic Factors 149
Study of apoptosis induction and deoxycytidine kinase/cytidine deaminase modulation in the synergistic interaction of a novel ceramide analog and gemcitabine in pancreatic cancer cells 149
Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms. 148
Evaluation of vascular infiltration in resected patients for pancreatic cancer: comparison among multidetector CT, intraoperative findings and histopathology 147
. THE ROLE OF ABDOMINAL ULTRASOUND SCAN FOR THE FOLLOW-UP OF PANCREATIC CYSTIC LESIONS: A COST- SAVING AND SAFE ALTERNATIVE TO THE ROUTINE USE OF MRI? 146
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds 146
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 145
Treatment strategy for pancreatic IPMNs: prognostic impact of conservative surgery 145
Development of 3D models of pancreatic ductal adenocarcinoma via tissue engineering 143
PANCREATIC CYSTIC LESIONS’ FOLLOW-UP WITH ABDOMINAL ULTRASOUND SCAN: COULD IT PLAY AN ALTERNATIVE ROLE TO THE ROUTINE USE OF MRI? 142
New platforms for PDAC preclinical studies: 3d tissue engineered models based on primary cancer cells and synthetic scaffolds 141
ISHIKAWA TYPE B ADENOCARCINOMA OF THE PANCREATIC HEAD: DUODENO-PANCREATECTOMY WITHOUT VASCULAR RESECTION AN ONCOLOGICALLY ACCEPTABLE OPTION? 141
NSC631570 affects MMP9, HENT1, and SPARC expression in cell cultures of pancreatic cancer. Can we use it in combination with gemcitabine/nab-paclitaxel? 141
MICROSATELLITE INSTABILITY AND TUMOR VOLUME INVERSELY AFFECT EARLY PROGRESSION FREE SURVIVAL IN ADJUVANT SETTING OF PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: LIGHTS AND SHADOWS OF MOLECULAR PATHOLOGY AND IMMUNOTHERAPY 139
COMPARISON BETWEEN ROBOTIC ASSISTED AND THE “GOLD STANDARD” OPEN APPROACH FOR LEFT SIDE CYSTIC TUMOR OF THE PANCREAS: RESULTS FROM A SINGLE CENTER 138
Intra-pancreatic fat mononuclear cell infiltration: A link between visceral fat accumulation and beta-cell failure in human type 2 diabetes? 137
The occurrence of prion protein in surgically resected pancreatic adenocarcinoma 137
EARLY MONOCENTRIC EXPERIENCE IN EUS-FNA WET-TECHNIQUE FOR PANCREATIC LESIONS 136
HEPATOSTEATOSIS AND ISLET ISOLATION 135
Mononuclear cell infiltration of intra-pancreatic fat and decreased islet beta cell area in human type 2 diabetes 135
Prognostic impact of conservative surgery for pancreatic IPMNs 129
The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms. 127
Silver nanoparticle-coated polyhydroxyalkanoate based electrospun fibers for wound dressing applications 127
APOPTOSIS IN A SERIES OF GEP-NET 125
Synergistic Interaction of Novel Lactate Dehydrogenase Inhibitors with Gemcitabine in Hypoxic Models of Pancreatic Cancer 124
Tissue microarray-chip featuring computerized immunophenotypical characterization more accurately subtypes ampullary adenocarcinoma than routine histology 124
PANCREATIC CYSTIC LESIONS IN FOLLOW-UP: COULD ABDOMINAL ULTRASOUND SCAN REPRESENT A SAFE AND COST-SAVING ALTERNATIVE TO MRI? 123
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study 123
Cheilognatopalatoschisi: Analisi morfologica ed istoenzimatica del muscolo orbicolare della bocca 122
3D In Vitro Model of Pancreatic Ductal Adenocarcinoma: New Strategy to Study Pancreatic Ductal Carcinoma 120
LASER MICRODISSECTION (LMD) AND PRIMARY CELL CULTURES IMPROVE PHARMACOGENETIC ANALYSIS IN PANCREATIC ADENOCARCINOMA ALLOWING THE USE OF GENE EXPRESSION LEVELS AND WHO GRADING AS PROGNOSTIC MARKERS 119
Unilateral Adrenal Hyperplasia in the Presence of a Reninoma in a Young Pregnant Woman 119
DOES INTRAPANCREATIC FAT ACCUMULATION INFLUENCE ISLETS FUNCTION AND SURVIVAL IN TYPE 2 DIABETIC PATIENTS? A STUDY WITH ISOLATED PANCREATIC ISLETS 118
IDENTIFICATION OF PATHOLOGICAL AMPULLARY ADENOCARCINOMAS SUBTYPES AND THEIR PROGNOSIS USING THE IMMUNOHISTOCHEMICAL SCORE OF CDX2, CK7 AND CK 20 118
P53 STATUS AND RESPONSE TO GEMCITABINE BASED THERAPY IN PANCREATIC CARCINOMA PATIENTS 117
ROBOTIC ASSISTED VERSUS OPEN LEFT PANCREATECTOMY FOR CYSTIC TUMORS: A SINGLE CENTER EXPERIENCE 117
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer 115
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 114
TUMOR VOLUME AND MICROSATELLITE INSTABILITY INVERSELY AFFECT EARLY PROGRESSION FREE SURVIVAL IN ADJUVANT SETTING OF PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: LIGHTS AND SHADOWS OF MOLECULAR PATHOLOGY AND IMMUNOTHERAPY 114
Totale 21.471
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.561
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021200 0 0 0 0 0 0 0 0 0 0 46 154
2021/20221.380 18 89 38 81 246 183 45 93 51 57 132 347
2022/20231.766 197 265 147 131 223 213 20 114 297 14 120 25
2023/20247.170 167 163 201 98 243 278 64 51 23 5.645 90 147
2024/20253.651 39 130 40 239 400 427 284 180 381 499 312 720
2025/20263.864 258 446 448 267 477 350 686 188 313 394 37 0
Totale 23.106